BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 17537393)

  • 1. Extending the capabilities of nature's most versatile catalysts: directed evolution of mammalian xenobiotic-metabolizing P450s.
    Gillam EM
    Arch Biochem Biophys; 2007 Aug; 464(2):176-86. PubMed ID: 17537393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the potential of xenobiotic-metabolising enzymes as biocatalysts: evolving designer catalysts from polyfunctional cytochrome P450 enzymes.
    Gillam EM
    Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):147-52. PubMed ID: 15743395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directed evolution of cytochrome P450 enzymes for biocatalysis: exploiting the catalytic versatility of enzymes with relaxed substrate specificity.
    Behrendorff JB; Huang W; Gillam EM
    Biochem J; 2015 Apr; 467(1):1-15. PubMed ID: 25793416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Versatile capacity of shuffled cytochrome P450s for dye production.
    Rosic NN
    Appl Microbiol Biotechnol; 2009 Feb; 82(2):203-10. PubMed ID: 19107474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 monooxygenases: perspectives for synthetic application.
    Urlacher VB; Eiben S
    Trends Biotechnol; 2006 Jul; 24(7):324-30. PubMed ID: 16759725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation.
    Joo H; Lin Z; Arnold FH
    Nature; 1999 Jun; 399(6737):670-3. PubMed ID: 10385118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of cytochrome P450 enzymes as biocatalysts in drug discovery and development.
    Gillam EM; Hayes MA
    Curr Top Med Chem; 2013; 13(18):2254-80. PubMed ID: 24047135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial P450s.
    Omura T
    Chem Biol Interact; 2006 Oct; 163(1-2):86-93. PubMed ID: 16884708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress towards the easier use of P450 enzymes.
    Chefson A; Auclair K
    Mol Biosyst; 2006 Oct; 2(10):462-9. PubMed ID: 17216026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome mining approach for the discovery of novel cytochrome P450 biocatalysts.
    Furuya T; Kino K
    Appl Microbiol Biotechnol; 2010 Apr; 86(4):991-1002. PubMed ID: 20177889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochromes P450 of insects: the tip of the iceberg.
    Scott JG; Wen Z
    Pest Manag Sci; 2001 Oct; 57(10):958-67. PubMed ID: 11695190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications.
    Hollenberg PF; Kent UM; Bumpus NN
    Chem Res Toxicol; 2008 Jan; 21(1):189-205. PubMed ID: 18052110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial P450 enzymes in biotechnology.
    Urlacher VB; Lutz-Wahl S; Schmid RD
    Appl Microbiol Biotechnol; 2004 Apr; 64(3):317-25. PubMed ID: 14716467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification.
    Iyanagi T
    Int Rev Cytol; 2007; 260():35-112. PubMed ID: 17482904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directed evolution of biocatalytic processes.
    Hibbert EG; Baganz F; Hailes HC; Ward JM; Lye GJ; Woodley JM; Dalby PA
    Biomol Eng; 2005 Jun; 22(1-3):11-9. PubMed ID: 15857779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering cytochrome P450 enzyme systems for biomedical and biotechnological applications.
    Li Z; Jiang Y; Guengerich FP; Ma L; Li S; Zhang W
    J Biol Chem; 2020 Jan; 295(3):833-849. PubMed ID: 31811088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending the diversity of cytochrome P450 enzymes by DNA family shuffling.
    Rosic NN; Huang W; Johnston WA; DeVoss JJ; Gillam EM
    Gene; 2007 Jun; 395(1-2):40-8. PubMed ID: 17400405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome.
    Niwa T; Murayama N; Yamazaki H
    Curr Drug Metab; 2009 Sep; 10(7):700-12. PubMed ID: 19594405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochromes P450 as useful biocatalysts: addressing the limitations.
    O'Reilly E; Köhler V; Flitsch SL; Turner NJ
    Chem Commun (Camb); 2011 Mar; 47(9):2490-501. PubMed ID: 21264369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.